-
November 02, 2012
Novo Nordisk (NVO) reported second quarter 2012 earnings of $1.67 per American Depository Receipt (ADR), up 20.1% ...
-
October 31, 2012
Dr. Reddy's Laboratories (RDY) reported second quarter fiscal 2013 earnings per American Depositary Share (ADS) of ...
-
October 26, 2012
Sanofi (SNY) reported third quarter 2012 business earnings of $1.05 per American Depositary Share (ADS), much lower ...
-
October 26, 2012
AstraZeneca's (AZN) third quarter 2012 core earnings of $1.51 per American Depositary Share (ADS) beat the Zacks ...
-
October 24, 2012
Over the recent past, Life Technologies (LIFE) has been focusing on developing its diagnostics franchise. Earlier ...
-
October 24, 2012
Bristol-Myers Squibb Company's (BMY) second quarter 2012 earnings (excluding special items) of 48 cents per share ...
-
October 24, 2012
Bristol-Myers Squibb Company (NYSE:BMY) announced its results for the most recent quarter on October 24, 2012. ...
-
October 22, 2012
Jazz Pharmaceuticals plc (JAZZ) recently completed the sale of its women's health business to Meda Pharmaceuticals ...
-
October 19, 2012
When Bristol-Myers Squibb (NYSE:BMY) releases its third quarter earnings on Wednesday, October 24, 2012, analysts ...
-
October 16, 2012
Bristol-Myers Squibb Company (BMY) recently announced that the US Food and Drug Administration (FDA) has cleared a ...
-
October 16, 2012
Abbott Laboratories (ABT) recently announced promising data from the phase IIb Aviator trial evaluating the ...
-
October 16, 2012
Strong September retail sales data coupled with better-than-expected quarterly results by Citigroup drove the ...
-
October 09, 2012
Following the genericization of blood thinner Plavix and hypertension treatment Avapro/Avalide in major markets ...
-
October 09, 2012
Life Technologies (LIFE) is on an acquisition bandwagon, targeted towards building its diagnostics franchise. The ...
-
October 09, 2012
AstraZeneca (AZN) recently announced that it has entered into a global exclusive licensing agreement with Ardelyx ...
-
October 02, 2012
ARIAD Pharmaceuticals, Inc. (ARIA) recently completed the rolling submission of the New Drug Application (NDA) for ...
-
September 27, 2012
The US approval process of Bristol-Myers Squibb Company/Pfizer Inc.'s (BMY/PFE) anti-clotting drug Eliquis ...
-
September 26, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently provided ...
-
September 26, 2012
Over the recent past Life Technologies (LIFE) has been focusing on expanding its diagnostics portfolio. To achieve ...
-
September 24, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner, Pfizer Inc. (PFE) received some encouraging news with the ...
